切换至 "中华医学电子期刊资源库"

中华结直肠疾病电子杂志 ›› 2019, Vol. 08 ›› Issue (02) : 131 -134. doi: 10.3877/cma.j.issn.2095-3224.2019.02.005

所属专题: 文献

论著

美沙拉秦联合肠胃宁治疗溃疡性结肠炎疗效及对TGF-β1、IGF-1的影响
沈秉正1, 祝成亮2, 胡振夏1, 李丹1, 王娜1, 陈莹1, 李景1, 喻研3,()   
  1. 1. 430060 武汉大学人民医院药学部
    2. 430060 武汉大学人民医院检验科
    3. 430030 华中科技大学同济医学院附属同济医院消化内科
  • 收稿日期:2018-03-27 出版日期:2019-04-25
  • 通信作者: 喻研
  • 基金资助:
    国家自然科学基金资助项目(No.31700086); 病毒学国家重点实验室开放研究基金资助项目(No.2016KF002)

The curative effect of the salad oxazine combined with Chang weining in treating ulcerative colitis and the influences on TGF-β and IGF-1

Bingzheng Shen1, Chengliang Zhu2, Zhenxia Hu1, Dan Li1, Na Wang1, Ying Chen1, Jing Li1, Yan Yu3,()   

  1. 1. Department of Pharmacy, Renmin Hospital of Wuhan University, Wuhan 430060, China
    2. Department of Clinical Laboratory, Renmin Hospital of Wuhan University, Wuhan 430060, China
    3. Department of Gastroenterology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 43030, China
  • Received:2018-03-27 Published:2019-04-25
  • Corresponding author: Yan Yu
  • About author:
    Corresponding author: Yu Yan, Email:
引用本文:

沈秉正, 祝成亮, 胡振夏, 李丹, 王娜, 陈莹, 李景, 喻研. 美沙拉秦联合肠胃宁治疗溃疡性结肠炎疗效及对TGF-β1、IGF-1的影响[J/OL]. 中华结直肠疾病电子杂志, 2019, 08(02): 131-134.

Bingzheng Shen, Chengliang Zhu, Zhenxia Hu, Dan Li, Na Wang, Ying Chen, Jing Li, Yan Yu. The curative effect of the salad oxazine combined with Chang weining in treating ulcerative colitis and the influences on TGF-β and IGF-1[J/OL]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2019, 08(02): 131-134.

目的

探究美沙拉秦联合肠胃宁治疗初发型溃疡性结肠炎疗效及对患者血清细胞因子TGF-β1、IGF-1水平的影响。

方法

选取来自武汉大学人民医院消化内科就诊并接受治疗的初发型溃疡性结肠炎患者44例,单药治疗组20例仅口服美沙拉秦,联合用药组24例口服美沙拉秦及肠胃宁,对比两组患者临床疗效;选取16例健康人为正常对照组,检测并比较患者治疗前后血清细胞因TGF-β1及IGF-1水平。

结果

联合用药组经过治疗后总有效率(79.17%)高于单药治疗组(50.00%),差异具有统计学意义(χ2=4.13,P=0.04)。正常对照组TGF-β1及IGF-1水平分别为(108.50±18.99)ng/L和(255.25±17.41)ng/L;经药物治疗后,联合用药组[(92.46±16.76)ng/L、(221.25±11.56)ng/L]比单药治疗组[(79.45±14.44 ng/L),(181.80±12.12 ng/L)]变化更显著。与治疗前比较,两组患者TGF-β1及IGF-1水平均升高,差异具有统计学意义(单一药物组:t=-4.16,P=0.001;t=-14.22,P=0.000)(联合用药组:t=-8.49,P=0.000;t=-26.7,P=0.000);与单药治疗组相比,治疗后联合用药组患者细胞因子TGF-β1及IGF-1水平升高更显著,差异具有统计学意义(t=2.02,P=0.01;t=2.02,P<0.001)。

结论

将美沙拉秦与肠胃宁联用能够提高总有效率,患者血清TGF-β1及IGF-1含量更接近正常对照组。

Objective

To explore the curative effects and influences of the serum cytokines level in patients with UC after the medication treatment combined salad oxazine with Chang weining.

Methods

Selecting forty-four patients with UC who came to Renmin Hospital of Wuhan University and accepted medication treatment. Twenty patients were only treated with salad oxazine and other twenty-four patients were treated with salad oxazine and Chang weining, then clinical efficacy was compared between the two groups. In addition, sixteen healthy people were chosen as normal control group, and the serum cytokine level of TGF-β and IGF-1 in two groups were measured before and after treatment with medications.

Results

After treatments, the total efficiency of combination group (79.17%) was higher than that of single drug treatment group (50.00%), and the difference presented statistically significant (χ2=4.13, P=0.04). The levels of TGF-β1 and IGF-1 in the normal control group were (108.50±18.99) ng/L and (255.25±17.41) ng/L, respectively. After treatment, the combined drug treatment group [(92.46±16.76) ng/L, (221.25±11.56) ng/L] presented more significant changes than single drug treatment group [(79.45±14.44) ng/L, (181.80±12.12) ng/L]. Compared with the of serum cytokine level before treatment, both TGF-β and IGF-1 levels in two groups were increased, and the difference was statistically significant (single drug treatment group: t=-4.16, P=0.001; t=-14.22, P=0.000) (combined drug treatment group: t=-8.49, P=0.000; t=-26.7, P=0.000). Compared with the single drug treatment group, the level of cytokine in patients with combined drug treatment group was significantly higher, and the difference was statistically significant (t=2.02, P=0.01; t=2.02, P<0.001).

Conclusions

The total effective rate was increased by the combination of salad oxazine and Chang weining, and the serum cytokine level of TGF-β1 and IGF-1 of combination group were closer to the normal control group.

表1 两组患者基本情况比较
表2 两组患者治疗后临床治疗效果对比[例(%)]
表3 两组患者药物治疗前后血清细胞因子含量分析(ng/L,±s
[1]
钱家鸣,杨红. 中国炎症性肠病研究现状和展望[J]. 中华炎性肠病杂志, 2017, 1(1):2-4.
[2]
刘笃佳,王媛媛,马旭. 溃疡性结肠炎的流行病学研究进展[J]. 中国烧伤创疡杂志, 2017, 29(3):214-217.
[3]
Wang YN, Li J, Zheng WY, et al. Clinical characteristics of ulcerative colitis related colorectal cancer in Chinese patients [J]. J Dig Dis, 2017, 18(12):684-690.
[4]
Yoshino T, Nakase H, Takagi T, et al. Risk factors for developing colorectal cancer in Japanese patients with ulcerative colitis: a retrospective observational study-CAPITAL (Cohort and Practice for IBD total management in Kyoto-Shiga Links) study I [J]. BMJ Open Gastroenterol, 2016, 3(1):e000122.
[5]
Caini S, Bagnoli S, Palli D, et al. Total and cancer mortality in a cohort of ulcerative colitis and Crohn′s disease patients: The Florence inflammatory bowel disease study, 1978-2010 [J]. Dig Liver Dis, 2016, 48(10):1162-1167.
[6]
张声生,沈洪,郑凯, 等. 溃疡性结肠炎中医诊疗专家共识意见(2017) [J]. 中华中医药杂志, 2017, 32(8):3585-3589.
[7]
中华医学会消化病学分会炎症性肠病学组. 炎症性肠病诊断与治疗的共识意见(2012年·广州) [J]. 胃肠病学, 2012, 51(12):763-781.
[8]
中华医学会病理学分会消化病理学组筹备组. 中国炎症性肠病组织病理诊断共识意见[J]. 中华病理学杂志, 2014, 43(4):268-274.
[9]
张娜,周璐,曹晓沧, 等. 初发型溃疡性结肠炎患者的长期随访(附37例病例分析) [J]. 天津医科大学学报, 2012, 18(1):89-92.
[10]
李军祥,谭祥,毛堂友. 溃疡性结肠炎中西医结合治疗策略[J]. 中国中西医结合杂志, 2017, 37(4):398-400.
[11]
干丹,韩昌鹏. 中西医结合治疗溃疡性结肠炎的研究进展[J]. 现代中西医结合杂志, 2017, 26(26):2958-2961.
[12]
胥靖域,顾三元,王菊, 等. TGF-β1与溃疡性结肠炎的相关性研究[J]. 实用中西医结合临床, 2013, 13(7):1-3.
[13]
李苁,黄德强. TGF-β在炎症性肠病肠纤维化中的作用[J]. 实用临床医学, 2017, 18(5):104-107.
[14]
Dubash AD, Kam CY, Aguado BA, et al. Plakophilin-2 loss promotes TGF-β1/p38 MAPK-dependent fibrotic gene expression in cardiomyocytes [J]. J Cell Biol, 2016, 212(4):425-438.
[15]
王俊珊,刘占举,郑萍, 等. 胰岛素样生长因子与炎症性肠病活动度和病变范围的相关性[J].上海医学, 2010, 33(1):104-106.
[16]
Zatorski H, Marynowski M, Fichna J. Is insulin-like growth factor 1 (IGF-1) system an attractive target inflammatory bowel diseases? Benefits and limitation of potential therapy [J]. Pharmacological Reports, 2016, 68(4):809-815.
[1] 张启龙, 柳亿, 卢会丽, 罗慧, 李成林, 王菁, 王辉. 奥妥珠单抗治疗磷脂酶A2受体相关膜性肾病的疗效与安全性:单中心回顾性分析[J/OL]. 中华危重症医学杂志(电子版), 2024, 17(05): 379-384.
[2] 王杰, 袁泉, 王玥琦, 乔佳君, 谭春丽, 夏仲元, 刘守尧. 溃疡油在糖尿病足溃疡治疗中的应用效果及安全性观察[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(06): 480-484.
[3] 聂生军, 王钰, 王毅, 鲜小庆, 马生成. 复方倍他米松局部注射联合光动力疗法治疗小型瘢痕疙瘩的临床疗效观察[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(05): 404-410.
[4] 莫淇舟, 苏劲, 黄健, 李健维, 李思宁, 柳建军. 智能控压输尿管软镜碎石吸引取石术在直径10~25 mm上尿路结石中的应用[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(05): 497-502.
[5] 李义亮, 苏拉依曼·牙库甫, 麦麦提艾力·麦麦提明, 克力木·阿不都热依木. 机器人与腹腔镜食管裂孔疝修补术联合Nissen 胃底折叠术短期疗效分析[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(05): 512-517.
[6] 周艳, 李盈, 周小兵, 程发辉, 何恒正. 不同类型补片联合Nissen 胃底折叠术修补食管裂孔疝的疗效及复发潜在危险因素[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(05): 528-533.
[7] 王小琴, 汪丽, 崔建英. 无张力疝修补术治疗慢性肾功能衰竭合并腹股沟疝患者的疗效[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(05): 538-542.
[8] 梁艳娉, 列诗韵, 王艺穗, 吴晓瑛, 林颖. 基于内镜操作细节记录系统构建胃底静脉曲张内镜下组织胶注射术的标准化管理方案[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 705-709.
[9] 陈杰, 武明胜, 李一金, 李虎, 向源楚, 荣新奇, 彭健. 低位直肠癌冷冻治疗临床初步分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 494-498.
[10] 董晓斌, 张静, 苏莎莎, 莎比亚·沙吾提, 盛好. 溃疡性结肠炎患者相关环状RNA 差异表达谱分析及功能研究[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 499-509.
[11] 史彬, 司远. 益气和络方联合缬沙坦治疗气阴两虚兼血瘀证IgA 肾病的疗效观察[J/OL]. 中华肾病研究电子杂志, 2024, 13(06): 306-312.
[12] 韩俊岭, 王刚, 马厉英, 连颖, 徐慧. 维生素D 联合匹维溴铵治疗腹泻型肠易激综合征患者疗效及对肠道屏障功能指标的影响研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 560-564.
[13] 陈利, 杨长青, 朱风尚. 重视炎症性肠病和代谢相关脂肪性肝病间的串话机制研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(05): 385-389.
[14] 阳跃, 庹晓晔, 崔子豪, 欧阳四民, 林海阳, 胡景宇, 胡银, 李涛, 赵景峰, 郝岱峰, 冯光. 改良“阅读者”皮瓣修复骶尾部压疮的疗效[J/OL]. 中华临床医师杂志(电子版), 2024, 18(08): 751-755.
[15] 克地尔牙·马合木提, 胡波, 杨琼, 闫素, 胡岚卿, 高沛沛, 姚恩生. 依达拉奉右莰醇对急性脑梗死后认知功能障碍的疗效观察[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(05): 459-466.
阅读次数
全文


摘要